Treatment for SUI

Stress Urinary Incontinence Spectrum

Injectable products have an important role to play within the SUI treatment offerings. However, current UBAs are mostly a last resort treatment option for women unable or unwilling to undergo a surgical procedure, or after a failed surgical intervention. Urolon now represents a new opportunity for these women. Urolon has the potential to address a much wider population of women suffering with SUI; especially those who currently do not come forward for treatment, opting to try to manage their condition alone, or prefer not to have a non-resorbable, permanent implant.

The below graph shows the position of Urolon in the SUI treatment spectrum: start with a minimally invasive bioresorbable urethral implant! Keep surgical and permanent options for later!

urolon, urethral bulking agent, UBA, slings, pfmt, pelvic floor muscle training, pads, stress urinary incontinence, SUI

Minimally Invasive Treatment

Urolon represents a minimally invasive treatment opportunity for women with mild to moderate SUI where pelvic floor muscle training is not sufficient or adherence to training is not met. This same group may not feel ready to consider a surgical option, yet would benefit from a treatment that aims at symptom reduction and prevention.